BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 33411113)

  • 1. Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study.
    Tanaka K; Saito H; Iwasaki T; Oda A; Watanabe S; Kanno M; Kimura H; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
    Clin Exp Nephrol; 2021 Apr; 25(4):410-417. PubMed ID: 33411113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.
    Nakhoul GN; Huang H; Arrigain S; Jolly SE; Schold JD; Nally JV; Navaneethan SD
    Am J Nephrol; 2015; 41(6):456-63. PubMed ID: 26228532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes.
    Collins AJ; Pitt B; Reaven N; Funk S; McGaughey K; Wilson D; Bushinsky DA
    Am J Nephrol; 2017; 46(3):213-221. PubMed ID: 28866674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study.
    Chen Y; Chang AR; McAdams DeMarco MA; Inker LA; Matsushita K; Ballew SH; Coresh J; Grams ME
    Mayo Clin Proc; 2016 Oct; 91(10):1403-1412. PubMed ID: 27499535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis.
    Kovesdy CP; Matsushita K; Sang Y; Brunskill NJ; Carrero JJ; Chodick G; Hasegawa T; Heerspink HL; Hirayama A; Landman GWD; Levin A; Nitsch D; Wheeler DC; Coresh J; Hallan SI; Shalev V; Grams ME;
    Eur Heart J; 2018 May; 39(17):1535-1542. PubMed ID: 29554312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink.
    Furuland H; McEwan P; Evans M; Linde C; Ayoubkhani D; Bakhai A; Palaka E; Bennett H; Qin L
    BMC Nephrol; 2018 Aug; 19(1):211. PubMed ID: 30134846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study.
    Korgaonkar S; Tilea A; Gillespie BW; Kiser M; Eisele G; Finkelstein F; Kotanko P; Pitt B; Saran R
    Clin J Am Soc Nephrol; 2010 May; 5(5):762-9. PubMed ID: 20203167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of dyskalemia at admission and early dyskalemia correction on survival and cardiac events of critically ill patients.
    Bouadma L; Mankikian S; Darmon M; Argaud L; Vinclair C; Siami S; Garrouste-Orgeas M; Papazian L; Cohen Y; Marcotte G; Styfalova L; Reignier J; Lautrette A; Schwebel C; Timsit JF;
    Crit Care; 2019 Dec; 23(1):415. PubMed ID: 31856891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma potassium, diuretic use and risk of developing chronic kidney disease in a predominantly White population.
    Kieneker LM; Eisenga MF; Joosten MM; de Boer RA; Gansevoort RT; Kootstra-Ros JE; Navis G; Bakker SJ
    PLoS One; 2017; 12(3):e0174686. PubMed ID: 28346526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The prevalence, influencing factors and prognosis of abnormal serum potassium levels in patients with chronic kidney disease].
    Wang F; Yang C; Gao BX; Zhang LX; Zhao MH; Wang JW
    Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(42):3459-3465. PubMed ID: 34775702
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK.
    Linde C; Qin L; Bakhai A; Furuland H; Evans M; Ayoubkhani D; Palaka E; Bennett H; McEwan P
    ESC Heart Fail; 2019 Apr; 6(2):280-290. PubMed ID: 30629342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyskalemia, its patterns, and prognosis among patients with incident heart failure: A nationwide study of US veterans.
    Matsushita K; Sang Y; Yang C; Ballew SH; Grams ME; Coresh J; Molnar MZ
    PLoS One; 2019; 14(8):e0219899. PubMed ID: 31393910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperkalemia and Hypokalemia in CKD: Prevalence, Risk Factors, and Clinical Outcomes.
    Gilligan S; Raphael KL
    Adv Chronic Kidney Dis; 2017 Sep; 24(5):315-318. PubMed ID: 29031358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of hyperkalemia with clinical outcomes in advanced chronic kidney disease.
    Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2019; 39(5):513-522. PubMed ID: 31027897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
    Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial and Ethnic Differences in Mortality Associated with Serum Potassium in Incident Peritoneal Dialysis Patients.
    Eriguchi R; Obi Y; Soohoo M; Rhee CM; Kovesdy CP; Kalantar-Zadeh K; Streja E
    Am J Nephrol; 2019; 50(5):361-369. PubMed ID: 31522173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up.
    de Rooij ENM; de Fijter JW; Le Cessie S; Hoorn EJ; Jager KJ; Chesnaye NC; Evans M; Windahl K; Caskey FJ; Torino C; Szymczak M; Drechsler C; Wanner C; Dekker FW; Hoogeveen EK;
    Am J Kidney Dis; 2023 Sep; 82(3):257-266.e1. PubMed ID: 37182596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Abnormal Serum Potassium Levels with Arrhythmias and Cardiovascular Mortality: a Systematic Review and Meta-Analysis of Observational Studies.
    Hoppe LK; Muhlack DC; Koenig W; Carr PR; Brenner H; Schöttker B
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):197-212. PubMed ID: 29679302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Potassium Levels and Short-Term Outcomes in Patients With ST-Segment Elevation Myocardial Infarction.
    Ma W; Liang Y; Zhu J; Yang Y; Tan H; Yu L; Gao X; Feng G; Li J
    Angiology; 2016 Sep; 67(8):729-36. PubMed ID: 26626107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Potassium Levels in Patients With Congestive Heart Failure: Occurrence, Risk Factors, and Clinical Outcomes: A Danish Population-Based Cohort Study.
    Thomsen RW; Nicolaisen SK; Hasvold P; Garcia-Sanchez R; Pedersen L; Adelborg K; Egfjord M; Egstrup K; Sørensen HT
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29789332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.